Showing results (2741-2750 of 3,662) with videos related to

Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|March 29, 2011
Phase II trial of paclitaxel and uracil--tegafur in metastatic breast cancer. TEGATAX trialC Villanueva, L Chaigneau, A Dufresne, et al.
Breast (Edinburgh, Scotland)|March 29, 2011
Establishing an evidence-base for breast cancer control in developing countriesMark Lodge, Marilys Corbex
Breast (Edinburgh, Scotland)|March 15, 2011
Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancerSilvia Dellapasqua, Manuelita Mazza, Debora Rosa, et al.
Breast (Edinburgh, Scotland)|June 22, 2019
Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter studyE Pons-Tostivint, L Daubisse-Marliac, P Grosclaude, et al.
Breast (Edinburgh, Scotland)|August 1, 2016
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experienceL Moscetti, P Vici, T Gamucci, et al.
Breast (Edinburgh, Scotland)|May 3, 2015
Factors influencing time between surgery and radiotherapy: A population based study of breast cancer patientsS Katik, M Gort, J J Jobsen, et al.
Breast (Edinburgh, Scotland)|April 30, 2015
Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancerAntónio E Pinto, Teresa Pereira, Giovani L Silva, et al.
Breast (Edinburgh, Scotland)|April 25, 2015
Simulation models in population breast cancer screening: A systematic reviewRositsa G Koleva-Kolarova, Zhuozhao Zhan, Marcel J W Greuter, et al.
Breast (Edinburgh, Scotland)|August 11, 2016
Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat lessAngela Toss, Juan Palazzo, Adam Berger, et al.
Breast (Edinburgh, Scotland)|August 23, 2025
Early prediction of menopausal status after chemotherapy in women with early breast cancer in order to optimize adjuvant endocrine therapyCharissa van Zwol-Janssens, Mandy M van Rosmalen, Esther Oomen-de Hoop, et al.
Pageof 367